Bone Therapeutics to Acquire Majority Share of Medsenic

Bone Therapeutics and Medsenic entered into a binding contribution agreement to combine the operations of both companies by means of a share for share exchange.

The resulting business, Biosenic, will broaden and derisk Bone Therapeutics' portfolio that targets a broad array of inflammatory and orthopedic indications.

Integrating both...

document icon

You are out of free articles for this month

Subscribe as a Guest for $0 and unlock a total of 5 articles per month.

You are out of five articles for this month

Subscribe as an Executive Member for access to unlimited articles, THE ORTHOPAEDIC INDUSTRY ANNUAL REPORT and more.


Julie Vetalice is ORTHOWORLD's Editorial Assistant. She has covered the orthopedic industry for over 20 years, having joined the company in 1999.

Contact Us